{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:25:45Z","timestamp":1792297545444,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.braindev.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T10:46:40Z","timestamp":1459162000000},"page":"723-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-5258","authenticated-orcid":false,"given":"Tomoya","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Natsume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Itomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiko","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2016.03.004_b0005","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","article-title":"A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children","volume":"53","author":"Duchowny","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2016.03.004_b0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2016.03.004_b0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox\u2013Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2016.03.004_b0020","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(94)90741-2","article-title":"Lamotrigine in infantile spasms","volume":"344","author":"Veggiotti","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2016.03.004_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007691-199904000-00008","article-title":"Lamotrigine serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and dosage implications","volume":"21","author":"Armijo","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2016.03.004_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007691-199706000-00002","article-title":"The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response","volume":"19","author":"Bartoli","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2016.03.004_b0035","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/sj.npp.1300831","article-title":"Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine","volume":"30","author":"Theis","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.braindev.2016.03.004_b0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.1992.tb04079.x","article-title":"Sodium valproate acutely inhibits lamotrigine metabolism","volume":"33","author":"Yuen","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2016.03.004_b0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-9236(96)90130-7","article-title":"Bidirectional interaction of valproate and lamotrigine in healthy subjects","volume":"60","author":"Anderson","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.braindev.2016.03.004_b0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1248\/bpb.35.487","article-title":"Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients","volume":"35","author":"Yamamoto","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.braindev.2016.03.004_b0055","series-title":"The treatment of epilepsy: principles and practice","year":"2011"},{"key":"10.1016\/j.braindev.2016.03.004_b0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.09.008","article-title":"Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy","volume":"57","author":"Gidal","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2016.03.004_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0920-1211(00)00160-1","article-title":"Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy","volume":"42","author":"Gidal","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2016.03.004_b0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100324","article-title":"Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects","volume":"83","author":"Chung","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.braindev.2016.03.004_b0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007691-199610000-00001","article-title":"Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication","volume":"18","author":"May","year":"1996","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2016.03.004_b0080","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"Effect of antiepileptic drug comedication on lamotrigine clearance","volume":"62","author":"Weintraub","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2016.03.004_b0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00228-007-0308-2","article-title":"Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions","volume":"63","author":"Reimers","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2016.03.004_b0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0920-1211(02)00033-5","article-title":"Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin","volume":"49","author":"Anderson","year":"2002","journal-title":"Epilepsy Res"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760416300213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760416300213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T20:53:39Z","timestamp":1536872019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760416300213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0387760416300213"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2016.03.004","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}